Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) - 9 months ended Sep. 30, 2018 - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2017 234,076,907      
Beginning balance, value at Dec. 31, 2017 $ 234,077 $ 108,000,923 $ (110,109,000) $ (1,874,000)
Common stock issued on exercise of warrants and options, shares 12,697,483      
Common stock issued on exercise of warrants and options, value $ 12,697 634,303   647,000
Common stock issued on conversion of notes payable, shares issued 7,374,125      
Common stock issued on conversion of notes payable, value $ 7,374 466,626   474,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   526,000   526,000
Fair value of options and warrants issued as compensation   340,000   340,000
Common stock issued for services, shares 50,000      
Common stock issued for services, value $ 50 11,950   12,000
Net loss     (2,139,000) (2,139,000)
Ending balance, shares at Sep. 30, 2018 251,198,515      
Ending balance, value at Sep. 30, 2018 $ 254,198 $ 109,979,802 $ (112,248,000) $ (2,014,000)